{"nct_id":"NCT00803049","title":"Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitting Multiple Sclerosis","status":"COMPLETED","status_verified_date":"2016-12","start_date":"2006-10","start_date_type":null,"primary_completion_date":"2015-12","primary_completion_date_type":"ACTUAL","completion_date":"2015-12","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["SNY"]}